A School Nurse Application of the ECHO Model

2019 ◽  
pp. 105984051986174
Author(s):  
Suzuho Shimasaki ◽  
Pamela Brunner Nii ◽  
Lisa Davis ◽  
Erin Bishop ◽  
Cari Berget ◽  
...  
Keyword(s):  
Diabetes Care ◽  
Chronic Conditions ◽  
Type I Diabetes ◽  
Models Of Care ◽  
School Nurses ◽  
Type I ◽  
Colorado School ◽  
Childhood Diseases ◽  
Survey Results

Type I diabetes (T1D) is one of the most common childhood diseases and Type 2 diabetes (T2D) is increasing at alarming rates. Given that children spend a great percentage of their time in school, this setting is a critical environment for models of care that lead to better management of this and other health conditions. The School Nurses Managing Diabetes Care ECHO was offered to Colorado school nurses to build their capacity in providing evidence-based management of T1D. The purpose of this effort was to (1) determine whether or not the model could be used as a tool of collaboration and dissemination for school nurses across Colorado and (2) assess the effectiveness of the “School Nurses Managing Diabetes Care” ECHO learning series. Post-series survey results demonstrated a 25% increase in self-efficacy ratings, moving learners from “average among my peers” toward “competent.” Additionally, all respondents planned to make one or more practice changes to improve care for students with T1D. Expanding the use of the ECHO model to implement intensive management of children and youth with T1D is critically important as rates of this and other chronic conditions continue to increase.

scholarly journals Exploring perceptions and use of the patient portal by young adults with type 1 diabetes: A qualitative study

2020 ◽  
Vol 26 (4) ◽  
pp. 2586-2596
Author(s):  
Kathy K Marsh ◽  
Ruth A Bush ◽  
Cynthia D Connelly
Keyword(s):  
Qualitative Study ◽  
Emerging Adults ◽  
Chronic Conditions ◽  
Type I Diabetes ◽  
Chronically Ill ◽  
Chronic Illnesses ◽  
Self Management ◽  
Type I ◽  
Patient Portal

Emerging adults have been raised in the digital age and are therefore prime candidates for using a patient portal to manage chronic conditions. The limited body of research both identifies the underutilization of the patient portal and suggests increased use of the portal for the chronically ill as a tool to alleviate caregiver stress, as well as a potential modality to assist emerging adults to manage their chronic illnesses. This qualitative study was completed to obtain an understanding of emerging adults familiarity with the electronic patient portal and to elicit the perception of the usefulness of the portal to support self-management of type I diabetes. Findings provide a preliminary understanding of how a sampling of emerging adults with type I diabetes uses, perceives the benefits of, and wants to improve technology for diabetes self-management.

scholarly journals Exploring the Interplay Between Oral Diseases, Microbiome, and Chronic Diseases Driven by Metabolic Dysfunction in Childhood

2021 ◽  
Vol 2 ◽  
Author(s):  
Fernanda Maria Sabella ◽  
Simone Nataly Busato de Feiria ◽  
Apoena de Aguiar Ribeiro ◽  
Letícia Helena Theodoro ◽  
José Francisco Höfling ◽  
...  
Keyword(s):  
Chronic Diseases ◽  
Type I Diabetes ◽  
Oral Microbiome ◽  
Entire Body ◽  
Type I ◽  
Metabolic Dysfunction ◽  
Oral Diseases ◽  
Future Health ◽  
Childhood Diseases ◽  
Inflammatory State

Oral childhood diseases, such as caries and gingivitis, have much more than a local impact on the dentition and tooth surrounding tissues, which can affect systemic conditions. While the mouth is frequently exposed to microbial stressors that can contribute to an inflammatory state in the entire body, chronic disorders can also interfere with oral health. Sharing common risk factors, a dynamic interplay can be driven between 1. dental caries, gingivitis, and type I diabetes mellitus, 2. early childhood caries and obesity, and 3. caries and cardiovascular diseases. Considering that there are ~2.2 billion children worldwide and that childhood provides unique opportunities for intervention targeting future health promotion, this review is of prime importance and aimed to explore the relationship between the oral microbiome and oral chronic diseases driven by metabolic dysfunction in childhood.

scholarly journals Platelet Activation and Platelet–Leukocyte Aggregates in Type I Diabetes Mellitus

2018 ◽  
Vol 24 (9_suppl) ◽  
pp. 230S-239S ◽  
Author(s):  
Asmaa M. Zahran ◽  
Omnia El-Badawy ◽  
Ismail L. Mohamad ◽  
Deiaaeldin M. Tamer ◽  
Safwat M. Abdel-Aziz ◽  
...  
Keyword(s):  
Platelet Activation ◽  
Type I Diabetes ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Control Group ◽  
Type I ◽  
Platelet Activity ◽  
Increased Risk

Hyperglycemia alone may not explain the increased risk of cardiovascular diseases (CVDs) in patients with type 1 diabetes (T1D) compared with type 2. This study emphases on the evaluation of some platelet activity markers in patients with T1D, with relevance to some metabolic disorders as hyperlipidemia and hyperglycemia. This study was performed on 35 patients with T1D and 20 healthy controls. All participants were subjected to full history taking, clinical examination and assay of glycated hemoglobin (HbA1c), and lipid profile. The expression of CD62P and CD36 on platelets and the frequency of platelet–monocyte, and platelet–neutrophil aggregates were assessed by flow cytometry. Patients showed significantly higher expression of CD62P and CD36 than the control group. Platelets aggregates with monocytes were also higher among patients than the control group. Levels of CD36+ platelets, CD62P+ platelets, and platelet–monocyte aggregates revealed significant correlations with the levels of HbA1c, total cholesterol, low-density lipoprotein, and triglycerides. Hyperlipidemia and hyperglycemia accompanying T1D have a stimulatory effect on platelet activation which probably makes those patients vulnerable to CVD than nondiabetics.

scholarly journals Estimating the Levels of Autoantibodies to NMDA And Dopamine Receptors in Children with Diabetes Mellitus Type I, Subject to the Condition Severity

Medicina ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 41-48
Author(s):  
Yu. V. Bykov ◽  
◽  
V. A. Baturin ◽  
T. I. Uglova ◽  
◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Nmda Receptors ◽  
Children And Adolescents ◽  
Dopamine Receptors ◽  
Type I Diabetes ◽  
Enzyme Linked Immunosorbent Assay ◽  
Type I ◽  
Diabetes Mellitus Type I ◽  
History Of

Type I Diabetes Mellitus (DM) is among the most common endocrinological diseases in adolescents. The purpose of this study was to research the level of autoantibodies (AAT) to NMDA receptors and Type 2 dopamine receptors (DAR2) in children with varying severity condition of Type I Diabetes. We examined 38 children and adolescents aged 2 to 17 years. In order to determine the levels of AAT to NMDA receptors and dopamine receptors (DR2) in blood serum, we applied the enzyme-linked immunosorbent assay (ELISA). We found higher levels of AAT to NMDA receptors and dopamine receptors (DAR2) in children with chronic Type I Diabetes against the background of diabetic ketoacidosis (DKA), as compared to children with the diabetes onset or compensation of the disease. The increased levels of AAT to NMDA and dopamine receptors (DAR2) were found in children and adolescents against the background of a long history of the disease and frequent hospitalization to the intensive care unit.

scholarly journals Adapting Protocols or Models for Use in Insulin-Requiring Diabetes and Islet Transplant Recipients

2021 ◽  
Vol 12 ◽  
Author(s):  
Glenn M. Ward ◽  
Jacqueline M. Walters ◽  
Judith L. Gooley ◽  
Raymond C. Boston
Keyword(s):  
Type I Diabetes ◽  
Type I ◽  
Transplant Recipients ◽  
Glucose Effectiveness ◽  
Islet Transplant ◽  
Glucose Challenge ◽  
Impaired Awareness ◽  
Islet Transplants ◽  
Made In

The authors’ perspective is described regarding modifications made in their clinic to glucose challenge protocols and mathematical models in order to estimate insulin secretion, insulin sensitivity and glucose effectiveness in patients living with Insulin-Requiring Diabetes and patients who received Pancreatic Islet Transplants to treat Type I diabetes (T1D) with Impaired Awareness of Hypoglycemia. The evolutions are described of protocols and models for use in T1D, and Insulin-Requiring Type 2 Diabetes (T2D) that were the basis for studies in the Islet Recipients. In each group, the need for modifications, and how the protocols and models were adapted is discussed. How the ongoing application of the adaptations is clarifying the Islet pathophysiology in the Islet Transplant Recipients is outlined.

Type 1 and 2 Diabetes Mellitus and Oral Health

2019 ◽  
Author(s):  
Goldberg M
Keyword(s):  
Type 2 Diabetes ◽  
Tooth Loss ◽  
Type I Diabetes ◽  
Type I ◽  
Obese Adults ◽  
Irritation Fibroma ◽  
Cardiovascular Illness

Diabetes is characterized by an elevated level of glucose in the blood.Type I diabetes mellitusresults from insulin deficiency. In contrast, type 2 diabetes results of insulin resistance.A third group recently identified confirmed that the secretory defects of gestational insulin are the consequence of abnormal glucose tolerance during pregnancy. Symptoms of diabetes include the classic triad [polyuria, polydipsia, polyphagia]. Long-term complications of diabetes include nephropathy and autoimmune cardiovascular illness dysfunctions. The symptoms of type 2 diabetes develop more slowly than type I diabetes. These patients may be obese. Adults develop micro- and macro- vascular conditions, producing irreversible damages to the eyes (retinopathy, cataracts), kidney (nephropathy), nervous system (neuropathy and parenthesis). Oral complications including candidiasis (fungal infection due to any type of Candida), dental caries, tooth loss, gingivitis, lichen planus, neurosensory disorders (burning mouth syndrome), periodontitis, salivary dysfunction, xerostomia, and taste impairment. Diabetes implicate greater prevalence of fissured tongue, irritation fibroma, traumaticulcers, and recurrent aphthous stomatitis. Hyperglycemia induces non-enzymatic elevated levels of glucose that stimulate interleukin-6 expression. Altogether these factors contribute to cardiovascular disease.

scholarly journals Tackling the silent epidemic of Type-I Diabetes Mellitus (Type-1 DM) through National Health Programmes- A narrative review of available evidence

2021 ◽  
Vol 33 (2) ◽  
pp. 245-249
Author(s):  
Om Prakash Bera ◽  
Vandana Shah ◽  
Sudip Bhattacharya ◽  
Sheikh Mohd Saleem
Keyword(s):  
Diabetes Mellitus ◽  
Type I Diabetes ◽  
Surveillance Systems ◽  
Type I ◽  
Diabetes Research ◽  
Age Group ◽  
Type 2 Dm ◽  
Central Registry

Type 1 diabetes mellitus (T1DM) is an autoimmune ?-cell destruction, usually leading to absolute insulin deficiency, insulin resistance, or by a combination of both. Both the incidence and prevalence of diabetes T1DM is suspected to be high in India, but in the absence of nation-wide registry, the possibility of exact numbers is unsure. Till date, studies done among the population have seen prevalence more than the incidence of the disease, which has led to late screening and diagnosis of the disease within the community settings. India is already suffering from the burden of type 2 DM, in the process of screening those, patients with T1DM are somewhat getting ignored. Furthermore, cost associated with the treatment expenditure and social status of the people suffering from the disease too have a role to consider which has been totally side-lined in national programmes like National Program for Control of Diabetes, Cardiovascular disease, and Stroke (NPCDCS). There is also scarcity of data on the incidence of T1DM which could aid in formulating better policy avenues for the patients suffering from the disease.  Reports on trends in T1DM are more commonly available from countries with better established public health surveillance systems and diabetes research infrastructure. From India, due to scarcity of data on T1DM, we had to rely on published literature of some major centers across the country. Results from the Indian Council of Medical Research (ICMR) first phase, till July 2011 which included 5546 patients found T1DM among 63.9% cases and predominately among children; at registration 11.1% had already developed chronic complication of T1DM. As India is already suffering from the burden of type 2 DM, during current management and treatment, the problem lies at various levels which needs to be addressed. We propose a setting based, life course approach for T1DM where every age group will have access to the health care system either directly or indirectly from intra-natal life till elderly age group through health approach based on scientific methods delivered through health system. In this regard a central registry having enumeration and provisioning of mandatory Insulin to all through a national policy being implemented by NPCDCS is what policy makers must take up at urgent bases if we want to bend the curve of rising T1DM and prevalence of overall diabetes in India.

GLYBURIDE VERSUS METFORMIN : NEONATAL COMPLICATIONS IN THE PHARMACOLOGICAL MANAGEMENT OF PATIENTS WITH GESTATIONAL DIABETES. SYSTEMATIC REVIEW OF THE LITERATURE.

2021 ◽  
pp. 77-81
Author(s):  
Alexander Garcia Castañeda ◽  
Maria Camila Ruiz ◽  
Carolina Garcia ◽  
Lida Marcela Vega Mesa ◽  
Gennifer Andrea Gomez Toloza ◽  
...  
Keyword(s):  
Gestational Diabetes ◽  
Type I Diabetes ◽  
Progressive Increase ◽  
Type I ◽  
Third Trimester ◽  
Pharmacological Management ◽  
High Blood Glucose ◽  
Blood Glucose Concentrations

Diabetes mellitus can be dened as a group of metabolic disorders characterized by high blood glucose concentrations (1) . In general, type I diabetes is frequently associated with a deciency secondary to the destruction of insulin-producing β cells (2) . Meanwhile, type II diabetes is the result of a progressive increase in insulin resistance with a relative decit of it (3) . On the other hand, gestational diabetes is dened by The American Diabetes Association (ADA) as one that is diagnosed in the second or third trimester that is not clearly type 1 or type 2 diabetes (4) .

scholarly journals SAT-636 The Fast-Evolving Connected Diabetes Care Landscape: Transforming Diabetes Care with Telehealth and Technology

2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
Brian Levine ◽  
Kelly Close ◽  
Robert Abraham Gabbay
Keyword(s):  
Diabetes Care ◽  
Chronic Conditions ◽  
Diabetes Management ◽  
Glucose Monitoring ◽  
Smartphone Apps ◽  
Care Providers ◽  
Rapid Pace ◽  
Evidence Generation ◽  
Improve Health

Abstract Background and Aims Recent years have brought about a new form of “connected diabetes care,” defined as digital diabetes management systems based around (1) smartphone apps, (2) devices with built-in connectivity, and (3) remote human and automated coaching and support. Given their potential to help improve health outcomes, the rapid pace of innovation, and the dearth of information about them to guide patients, providers, and payers, we provide an update on the landscape of and trends in connected diabetes care offerings. Methods Prominent connected diabetes care providers that have published results are categorized and characterized. Similarities and differences are identified and the state of available evidence is evaluated. Results Connected diabetes care offerings were analyzed for items including: health conditions managed, care team composition, connected medical devices, and evidence. We expect these players will further expand offerings across chronic conditions, strive to integrate more deeply with the traditional healthcare system, deploy greater automation to promote scalability, and find clever ways to promote and support the use of continuous glucose monitoring in type 2 diabetes. Future evidence generation for this field should have more standardized methodology. Conclusions The field of connected diabetes care has tremendous potential to improve outcomes, but it is in its infancy in terms of awareness, uptake, and effectiveness. Further, questions regarding offerings’ abilities to support most people with diabetes sustainably remain. However, existing evidence is sufficient to support further exploration and refinement of the model as the next step in team-based diabetes care.

scholarly journals Inhibition of CeramideDe NovoSynthesis with Myriocin Affects Lipid Metabolism in the Liver of Rats with Streptozotocin-Induced Type 1 Diabetes

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Krzysztof Kurek ◽  
Patrycja Wiesiołek-Kurek ◽  
Dominika M. Piotrowska ◽  
Bartłomiej Łukaszuk ◽  
Adrian Chabowski ◽  
...  
Keyword(s):  
Lipid Metabolism ◽  
Metabolic Diseases ◽  
De Novo ◽  
Type I Diabetes ◽  
Type I ◽  
Positive Effects ◽  
Ceramide Synthesis ◽  
Intracellular Signal

Nowadays diabetes is one of the most common metabolic diseases. Sphingolipids, which are vitally important constituents of intracellular signal transduction pathways, may be among the most pathogenic lipid moieties intermingled in the origin and development of diabetes. It is now well established that inhibition ofde novoceramide synthesis with myriocin exerts positive effects on lipid metabolism and glucose homeostasis in type 2 diabetes mellitus animal models. However, its influence on type I diabetes still remains unknown. Therefore, the scope of this paper is to fulfill that particular gap in our knowledge.

Sign in / Sign up

Export Citation Format

Share Document